Hyperfine, Inc. (HYPR) stock
HYPRNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/3021% below fair value
$0.61−0.02 (-3.05%)
Close on Nov 16, 2026Market cap $64.70MP/E –Yield –
Hyperfine total assets
Total assets on the balance sheet at the end of each period.
Hyperfine's total assets was $63.00M at Jun 30, 2026. For fiscal 2025 it was $55.26M, down 6.2% from the year before. The highest annual figure on record is $202.47M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $55.26M | -6.2% |
| FY2024 | Dec 31, 2024 | $58.90M | -37.5% |
| FY2023 | Dec 31, 2023 | $94.20M | -29.7% |
| FY2022 | Dec 31, 2022 | $134.05M | -33.8% |
| FY2021 | Dec 31, 2021 | $202.47M | +183.1% |
| FY2020 | Dec 31, 2020 | $71.53M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $63.00M | +39.3% |
| Q1 FY2026 | Mar 31, 2026 | $60.34M | +13.0% |
| Q4 FY2025 | Dec 31, 2025 | $55.26M | -6.2% |
| Q3 FY2025 | Sep 30, 2025 | $41.51M | -40.2% |
| Q2 FY2025 | Jun 30, 2025 | $45.23M | -41.0% |
| Q1 FY2025 | Mar 31, 2025 | $53.38M | -37.5% |
| Q4 FY2024 | Dec 31, 2024 | $58.90M | -37.5% |
| Q3 FY2024 | Sep 30, 2024 | $69.39M | -32.7% |
| Q2 FY2024 | Jun 30, 2024 | $76.61M | -32.0% |
| Q1 FY2024 | Mar 31, 2024 | $85.44M | -30.0% |
| Q4 FY2023 | Dec 31, 2023 | $94.20M | -29.7% |
| Q3 FY2023 | Sep 30, 2023 | $103.06M | -30.5% |
| Q2 FY2023 | Jun 30, 2023 | $112.61M | -30.4% |
| Q1 FY2023 | Mar 31, 2023 | $122.10M | -31.7% |
| Q4 FY2022 | Dec 31, 2022 | $134.05M | -33.8% |
| Q3 FY2022 | Sep 30, 2022 | $148.33M | -28.7% |
| Q2 FY2022 | Jun 30, 2022 | $161.71M | -22.3% |
| Q1 FY2022 | Mar 31, 2022 | $178.83M | -14.2% |
| Q4 FY2021 | Dec 31, 2021 | $202.47M | +183.1% |
| Q3 FY2021 | Sep 30, 2021 | $207.94M | – |
| Q2 FY2021 | Jun 30, 2021 | $208.25M | – |
| Q1 FY2021 | Mar 31, 2021 | $208.45M | – |
| Q4 FY2020 | Dec 31, 2020 | $71.53M | – |
See a number that looks wrong?